Inmed pharmaceuticals to present at the 2021 bio digital conference

Vancouver, british columbia, june 09, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and leading the clinical development of cannabinol (“cbn”), today announced that eric. a. adams, president and ceo of inmed, will present at 2021 bio digital, the premier biotech conference, which is being held virtually this year from june 10-11 and 14-18, 2021.
INM Ratings Summary
INM Quant Ranking